
San Diego, California – NuVasive Inc. officials announced that the company exhibited its portfolio of spinal products at Eurospine 2014 last week in Lyon, France. NuVasive also provided attending surgeons with workshops addressing the best practices for minimally invasive spine procedures as part of the company’s commitment to serve the needs of patients and surgeons in Europe.
As part of the product exhibition, NuVasive highlighted its products and procedures including XLIF, a minimally invasive surgical (MIS) procedure pioneered by NuVasive that is performed through the side of the body utilizing proprietary neuromonitoring and an integrated portfolio of instruments and specialized implants for treating a range of spinal pathologies.
Concurrent with Eurospine 2014, Nuvasive also announced the opening of the company’s European Center of Excellence (COE) in Amsterdam.
The Center will serve as NuVasive’s European commercial headquarters and function as the commercial hub for the European executive leadership and departments across marketing, surgeon education, sales, human resources, legal and other support functions. Meanwhile, the International Operations Center in Ireland, which was established in June, will remain the company’s international operational headquarters.
Russell Powers, executive vice president of international for NuVasive said, “Region specific events such as Eurospine are essential to our expansion efforts in Europe. The COE, along with the recently opened International Operations Center in Ireland, provide further infrastructure for NuVasive to execute on our market share taking strategy across Western Europe and the entire EMEA region. As the spine market continues to shift toward less invasive solutions, NuVasive is well-positioned, as a leading innovator in minimally invasive spine procedures and other less invasive solutions, to drive surgeon adoption of these solutions across Europe.”
Paul Kosters, senior vice president of the EMEA branch said, “The opening of the COE is an important milestone for NuVasive and a key inflection point for our company’s strategy to expand in EMEA. In the past year, we have expanded our footprint to include Spain and Poland. Additionally, we continued to build out our world-class leadership team in EMEA with the recent appointment of Phil Bradshaw as managing director for the United Kingdom. Phil brings nearly 20 years of experience in the medical device industry, including a decade with DePuy Synthes and most recently with Stryker. Phil’s extensive experience in various markets across Europe will be highly complementary as we continue to execute against our market share-taking strategy.”
Source: NuVasive
Get curated news on YOUR industry.
Enter your email to receive our newsletters.Latest from Today's Medical Developments
- Forkardt Hardinge strengthens market position with ATS Systems acquisition
- July is for learning – so drop in for this month’s second Manufacturing Lunch + Learn
- MMT expands capabilities with acquisition of Comco
- Essential strategies to protect your data
- TT Electronics achieves ISO 13485 medical certification at Mexicali EMS facility
- Boost productivity with Nidec's innovative MGC300
- Meet AEON: the future of humanoid robotics
- Okuma: Extraordinary Starts Where Limits End